Emulsifying, encapsulating and eliminating in one go
Ear health and hygiene with a novel twist.
Reig Jofre has launched Otospray 3E, which, due to its effectiveness and form of action, presents a novelty in the market of the hygiene and health of the ear.
Due to its formulation, Otospray 3E acts on the dirt and excess of cerumen present in the ear canal by emulsifying, encapsulating and eliminating them in a single action, thus contributing to the prevention of earwax. In a single spray, Otospray 3E all in one.
Otospray 3E is available in two forms: Otospray 3E 100 mL, suitable for adults and children over 6 years of age, and Otospray 3E Junior 50 mL for children from 2 years of age and adults requiring a smoother spray.
Otospray 3E expands the range for the overall health of the ear, which is combined with Otocerum, otic drops in solution, the market leader in Spain for the dissolution and painless removal of the earwax. Hygiene and prevention of excess of cerumen: Otospray 3E. Dissolution of the earwax: Otocerum.
In addition, Reig Jofre’s ENT range also has the exclusive license for Spain of Sterimar, isotonic sea water spray for the daily nasal hygiene of the whole family. Reig Jofre started the marketing of Otospray in Spain, where the company has a commercial network of over one hundred sales representatives, specialized in practitioner, hospital and pharmacy channels, while it is also planning to expand its commercialization in Europe.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance